• Home
  • Victims
    • Vaccine Victims Memorial
    • Gardasil & Silgard
      • G / S Australasia
        • G / S Australia
        • G / S New Zealand
      • G / S Europe
        • G / S Czech Republic
        • G / S Denmark
        • G / S France
        • G / S Germany
        • G / S Ireland
        • G / S Italy
        • G / S Norway
        • G / S Scotland
        • G / S Spain
        • G / S United Kingdom
      • G / S N. America
        • G / S Canada
        • G / S Mexico
        • G / S United States
      • G / S S. America
        • G / S Brazil
        • G/S Colombia
    • Cervarix
      • Cervarix Asia
        • Cervarix India
        • Cervarix Philippines
      • Cervarix Europe
        • Cervarix Czech
        • Cervarix Netherlands
        • Cervarix Scotland
        • Cervarix Slovakia
        • Cervarix Spain
        • Cervarix UK
      • Cervarix N. America
        • Cervarix Mexico
  • Resources
    • HPV Testing Resources
      • Pre-HPV Vaccination
      • Post-HPV Vaccination
    • Medical Professionals
    • Vaccine Injury Attorneys
    • Political Action Groups
    • Vaccine Groups
    • Vaccine Victims Hotline
  • SANE Vax Press Releases
  • Videos
    • Vaccine Safety Videos
    • Vaccine Victim Videos
    • Pharma Videos
  • About
    • About Us
    • Who We Are
    • Press Releases
    • SANE Vax in the News
    • Contact Us

SaneVax, Inc.

The First International HPV Vaccine Information Clearinghouse

  • NEWS
    • Government Agencies
      • African
      • Asian
      • Australasian
      • European
      • North American
      • South American
      • United Nations
      • WHO
    • Pharmaceutical Companies
      • CSL Biotherapies
      • GlaxoSmithKline
      • Inovio Pharmaceuticals
      • Liquidia Technologies
      • Merck & Co.
      • Novartis
      • Pfizer
      • Qiagen
      • Sanofi Aventis
      • Sanofi Pasteur MSD spmsd
      • Wyeth Laboratories
    • Science & Medicine
      • Cancer
      • Clinical Trials
      • Environmental Health
      • Heavy Metal Toxicity
      • HPV Science
      • Influenza
      • Meningitis
      • Pertussis
      • Pharmaceuticals
      • Rotavirus
      • STD’s
      • Vaccine Science
      • Women’s Health
    • Vaccine Adverse Events
    • Vaccine Injury Reporting
      • VAERS
      • VAMPSS
    • Vaccine Litigation
    • Vaccine Marketing
    • Vaccine Politics/People
    • Vaccine Victims
      • Cervarix Injuries
      • DTP/DTaP Injuries
      • Fluvax Injuries
      • Fluzone Injuries
      • Gardasil / Silgard Injuries
      • Menomune Injuries
      • MMR Injuries
      • Polio Vaccine Injuries
      • Synflorix Injuries
      • Yellow Fever Vaccine
    • Vaccines
      • Anthrax
      • Breast Cancer
      • Chicken Pox
      • Cholera
      • Combination Vaccines
      • Diphtheria
      • Hepatitis B
      • HPV
      • Influenza Vaccines
      • Malaria
      • Measles
      • Meningitis Vaccines
      • MRSA
      • Mumps
      • Norovirus
      • Pertussis Vaccines
      • Pneumococcal Disease
      • Polio
      • Rotavirus Vaccines
      • Shingles
      • Smallpox
      • TB
      • Tetanus
      • Typhoid
      • Yellow Fever Vaccine
    • Vaccines and the Media
  • WORLD NEWS
    • Africa
    • Asia
    • Australasia
    • Europe
    • North America
    • South America
  • RESEARCH
    • Cancer Research
    • Cervarix Vaccine
    • Gardasil/Silgard Vaccine
    • Human Pap. Research
    • Immunization Practices
    • Neurology
    • Vaccine Adjuvants
    • Vac. Ingredient Research
    • Vaccine Injuries
    • Vaccine Preservatives
    • Vaccine Related Research
    • Vaccine Safety
  • CITIZENS SPEAK
    • Cervical Cancer Debate
    • HPV Vax
      • Australian Concerns
      • Canadian Concerns
      • Irish Concerns
      • Spain Concerns
      • UK Concerns
      • United States Concerns

Africa's Rwanda Gets Merck Cervical Prevention Treatment

April 30, 2011 By Norma Leave a Comment

The land of Africa is the second largest continent in the world in both square mileage and population. Thus, it also has widespread disease and in turn, is a huge testing bed for new medications and procedures. This week Merck and Qiagen NV have announced collaboration in Rwanda to battle cervical cancer. Rwanda will be […]

Filed Under: Government Agencies, HPV, Pharmaceutical Companies, Rwanda Tagged With: cervical cancer prevention, Merck, Qiagen

Alternative Gardasil dosing schedules effective

April 15, 2011 By Norma Leave a Comment

By Nicole Blazek Patients that were administered the three-dose quadrivalent human papillomavirus vaccine (Gardasil, Merck) with longer intervals between each dose had similar immune responses to those administered the vaccine on a standard dosing schedule, new data indicate. “Clinicians can be reassured that if delays occur in administering the second and third doses of this […]

Filed Under: HPV, HPV Science, Merck & Co. Tagged With: cervical cancer prevention, flexible dosing schedule, HPV vaccine, Merck

Updates on the management of cervical pre-cancer discussed at Obs-Gyne expo

April 8, 2011 By Norma Leave a Comment

Currently cervical cancer accounts for 10% of all cancers worldwide, ranking as the third most commonly diagnosed cancer in the world. According to Prof. F. Xavier Bosch from the Cancer Epidemiology and Research Program at the Catalan Institute of Oncology in Barcelona, the idea that the MENA region is at low risk from gynaecological cancers […]

Filed Under: HPV, United Arab Emerites Tagged With: cervical cancer prevention

A little protection can be a dangerous thing

April 5, 2011 By Norma Leave a Comment

By Jacky Jones SECOND OPINION: HPV vaccination programme makes no economic sense, writes JACKY JONES  THE HSE is offering a new human papilloma virus (HPV) vaccination programme to young girls in first and second year at secondary school. The organisation plans to immunise more than 46,000 girls in 2011, at a cost of €4 million. Does […]

Filed Under: HPV, Ireland Tagged With: cervical cancer prevention

Mafraq Hospital Launches Outreach Campaign to Educate Young Women about Cervical Cancer

April 5, 2011 By Norma Leave a Comment

– Cervical cancer ranked second most common cancer worldwide, but nearly all cases can be prevented   – Fifty percent increase in Pap tests performed at Mafraq Hospital’s gynaecological clinic since campaign launched   Abu Dhabi, UAE: April 3, 2011- Mafraq Hospital has recently launched an awareness campaign to educate young women about Cervical Cancer. […]

Filed Under: United Arab Emerites Tagged With: cervical cancer prevention

  • « Previous Page
  • 1
  • …
  • 5
  • 6
  • 7
  • 8
  • Next Page »

Follow Us

SaneVax on FacebookSaneVax on TwitterSaneVax on LinkedInSaneVax on YoutubeSaneVax RSS Feed

Help Support SaneVax

Notice: We need your support. This massive research & presentation comes from a team of volunteers. We need your help to keep this critical information available.



SaneVax relies on support from participants like you. We are a 501 (c)(3) non-profit corporation, donations are tax deductible. Help keep this venue available and support the spirit – Thank you!

This Week’s Survivor

Gone After Gardasil: Santana, New Mexico

Categories

Links

  • Creating an HPV Industry
  • File a VAERS Report
  • Gardasil and Unexplained Deaths
  • HPV Industry Timeline
  • HPV Mechanisms of Action in Women
  • HPV Vaccine Fact Sheet
  • Petition: Rescind HPV Vaccine Approval
  • Presentation to the FDA
  • Supreme Court Arguments

HPV Vaccine VAERS Reports

Description 12/14/2019  TOTAL
Disabled 3,092
Deaths 523
Did Not Recover 13,072
Abnormal Smear 695
Cervical Cancer 186
Infertility 52
Life-threatening 1,001
Emergency Room 15,419
Hospitalized 6,448
Extended Hosp. Stay 304
Serious 9,497
Total Adverse Events 64,270

Access expanded report here.

Subscribe2


 

Log In

Featured Video

Former Rx Sales Rep. Tells Truth-Video

News

SaneVax News Blog!
News

Videos

Safety • Victims • Pharma
No Genetic Epidemic

Contact

Contact S.A.N.E.Vax
S.A.N.E.VAX log thumbnail

Copyright © 2025 SaneVax, Inc. · Site by TheWebElves.com a div. of KalaRhythms.org · Log in